Post by Früh Verpackungstechnik AG

Pharma Contract Manufacturing 2026 in Berlin was a valuable opportunity to gain insights, exchange perspectives, and strengthen our network. Among the presentations, one stood out in particular because it clearly confirmed a strategic direction we have already taken in pharma contract packaging. Three messages were especially relevant: • Combination products and drug delivery systems are becoming more central across the industry. • “Off-the-shelf” autoinjector platforms are gaining momentum. • As customers increasingly adopt platform-based solutions, CDMOs need scalable, platform-ready lines. For us, this reinforces the importance of our recent investments in autoinjector assembly and end packaging / toploading. By continuing to expand our machine setup and capabilities, we are strengthening our position to support future market requirements in pharma contract packaging. It was great to see this direction so clearly reflected in the conversations and presentations throughout the event. Markus Bischof Ivan Orlando #Pharma #ContractPackaging #Autoinjector #DrugDelivery #PCM2026 #PharmaManufacturing #Networking